Identification	O
of	O
Chlamydia	B:C0368903
trachomatis	I:C0368903
Antigens	I:C0368903
Recognized	O
by	O
T	B:C0039194
Cells	I:C0039194
From	O
Highly	O
Exposed	O
Women	B:C0043210
Who	O
Limit	O
or	O
Resist	O
Genital	B:C1263758
Tract	I:C1263758
Infection	I:C1263758
.	O

Natural	O
infection	B:C3714514
induces	O
partial	O
immunity	B:C0020964
to	O
Chlamydia	B:C0008151
trachomatis	I:C0008151
Identification	O
of	O
chlamydial	B:C0368903
antigens	I:C0368903
that	O
induce	O
interferon	B:C3539881
γ	I:C3539881
(	O
interferon	B:C3539881
γ	I:C3539881
)	O
secretion	B:C1327616
by	O
T	B:C0039194
cells	I:C0039194
from	O
immune	O
women	B:C0043210
could	O
advance	O
vaccine	B:C0597634
development	I:C0597634
.	O

IFN	B:C3539881
-γ	I:C3539881
production	O
by	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215
and	O
CD8	B:C0242629
(+	I:C0242629
)	I:C0242629
peripheral	B:C0229664
blood	I:C0229664
T	B:C0039194
cells	I:C0039194
from	O
58	O
high	O
-	O
risk	O
women	B:C0043210
was	O
measured	O
after	O
coculture	B:C0282547
with	O
antigen	B:C0003315
-	I:C0003315
presenting	I:C0003315
cells	I:C0003315
preincubated	O
with	O
recombinant	O
Escherichia	B:C0014834
coli	I:C0014834
expressing	O
a	O
panel	O
of	O
275	O
chlamydial	B:C0368903
antigens	I:C0368903
.	O

Quantile	B:C0034980
median	I:C0034980
regression	I:C0034980
analysis	I:C0034980
was	O
used	O
to	O
compare	O
frequencies	O
of	O
IFN	B:C3539881
-γ	I:C3539881
responses	B:C0301872
in	O
women	B:C0043210
with	O
only	O
cervical	O
infection	O
to	O
those	O
in	O
women	B:C0043210
with	O
endometrial	B:C0014180
infection	B:C3714514
and	O
frequencies	O
in	O
women	B:C0043210
who	O
remained	O
uninfected	O
for	O
over	O
1	O
year	O
to	O
those	O
in	O
women	B:C0043210
who	O
developed	O
incident	O
infection	B:C3714514
.	O

Statistical	B:C1710191
methods	I:C1710191
were	O
then	O
used	O
to	O
identify	O
proteins	B:C0033684
associated	O
with	O
protection	B:C0020964
.	O

A	O
higher	O
median	O
frequency	O
of	O
CD8	B:C0242629
(+)	I:C0242629

T	I:C0242629
-	I:C0242629
cell	I:C0242629
responses	B:C1318468
was	O
detected	O
in	O
women	B:C0043210
with	O
lower	B:C0441994
genital	B:C0700038
tract	I:C0700038
chlamydial	B:C0008149
infection	I:C0008149
,	O
compared	O
with	O
those	O
with	O
upper	B:C1282910
genital	B:C0700038
tract	I:C0700038
chlamydial	B:C0008149
infection	I:C0008149
(	O
13.8	O
%	O
vs	O
9.5	O
%	O
;	O
P	O
=04	O
)	O
,	O
but	O
the	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215

T	I:C0039215
-	I:C0039215
cell	I:C0039215
response	O
frequencies	O
were	O
not	O
different	O
.	O

Women	B:C0043210
who	O
remained	O
uninfected	O
displayed	O
a	O
greater	O
frequency	O
of	O
positive	O
CD4	B:C0039215
(+	I:C0039215
)	I:C0039215

T	I:C0039215
-	I:C0039215
cell	I:C0039215
responses	B:C1318468
(	O
29	O
%	O
vs	O
18	O
%	O
;	O
P	O
<	O
.0001	O
)	O
,	O
compared	O
with	O
women	B:C0043210
who	O
had	O
incident	O
infection	B:C3714514
,	O
while	O
the	O
frequencies	O
of	O
CD8	B:C0242629
(+	I:C0242629
)	I:C0242629

T	I:C0242629
-	I:C0242629
cell	I:C0242629
responses	B:C1318468
did	O
not	O
differ	O
.	O

A	O
subset	B:C1515021
of	O
proteins	B:C0033684
involved	O
in	O
central	B:C0025519
metabolism	I:C0025519
,	O
type	B:C3156721
III	I:C3156721
secretion	I:C3156721
,	O
and	O
protein	B:C0597295
synthesis	I:C0597295
were	O
associated	O
with	O
protection	B:C0020964
.	O

Investigations	O
in	O
naturally	O
exposed	O
women	B:C0043210
reveal	O
protective	O
responses	B:C1318468
and	O
identify	O
chlamydial	B:C1519887
vaccine	I:C1519887
candidate	I:C1519887
antigens	I:C1519887
.	O

